Crescent Capital BDC (NASDAQ:CCAP) Downgraded to Market Perform Rating by Keefe, Bruyette & Woods

Crescent Capital BDC (NASDAQ:CCAP) was downgraded by equities research analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating in a research note issued on Friday,Finviz reports. They presently have a $17.00 price objective on the stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 6.65% from the stock’s previous close.

Separately, Wells Fargo & Company dropped their price objective on shares of Crescent Capital BDC from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Monday, April 28th.

Crescent Capital BDC Stock Down 4.3%

Shares of NASDAQ CCAP opened at $15.94 on Friday. The stock has a fifty day moving average price of $16.22 and a 200 day moving average price of $18.09. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. Crescent Capital BDC has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a market cap of $590.74 million, a P/E ratio of 8.01 and a beta of 0.63.

Crescent Capital BDC (NASDAQ:CCAP) last posted its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.07). The company had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. Research analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.

Institutional Trading of Crescent Capital BDC

A number of hedge funds have recently made changes to their positions in CCAP. Redhawk Wealth Advisors Inc. bought a new position in Crescent Capital BDC during the 4th quarter valued at $659,000. Hennion & Walsh Asset Management Inc. raised its stake in shares of Crescent Capital BDC by 11.9% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company’s stock valued at $2,025,000 after purchasing an additional 11,161 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Crescent Capital BDC by 2.3% in the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock valued at $876,000 after purchasing an additional 1,006 shares in the last quarter. Montag A & Associates Inc. bought a new position in shares of Crescent Capital BDC during the fourth quarter worth about $35,000. Finally, Ieq Capital LLC grew its stake in Crescent Capital BDC by 2.6% in the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock worth $437,000 after purchasing an additional 584 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company’s stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.